{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:42:52Z","timestamp":1792096972376,"version":"4.4.0"},"reference-count":216,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["16672"],"award-info":[{"award-number":["16672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mycoses Study Group Education and Research Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In recent years, the global public health community has increasingly recognized the importance of antimicrobial stewardship (AMS) in the fight to improve outcomes, decrease costs, and curb increases in antimicrobial resistance around the world. However, the subject of antifungal stewardship (AFS) has received less attention. While the principles of AMS guidelines likely apply to stewarding of antifungal agents, there are additional considerations unique to AFS and the complex field of fungal infections that require specific recommendations. In this article, we review the literature on AMS best practices and discuss AFS through the lens of the global core elements of AMS. We offer recommendations for best practices in AFS based on a synthesis of this evidence by an interdisciplinary expert panel of members of the Mycoses Study Group Education and Research Consortium. We also discuss research directions in this rapidly evolving field. AFS is an emerging and important component of AMS, yet requires special considerations in certain areas such as expertise, education, interventions to optimize utilization, therapeutic drug monitoring, and data analysis and reporting.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa394","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T20:35:25Z","timestamp":1593203725000},"page":"S175-S198","source":"Crossref","is-referenced-by-count":171,"title":["Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium"],"prefix":"10.1093","volume":"222","author":[{"given":"Melissa D","family":"Johnson","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell E","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S","family":"Dodds Ashley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ostrosky-Zeichner","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Laboratory of Mycology Research, McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis","family":"Zaoutis","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of California, Davis, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Andes","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Medical Microbiology and Immunology, University of Wisconsin\u2013Madison, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Walsh","sequence":"additional","affiliation":[{"name":"Transplantation-Oncology Infectious Diseases, Weill Cornell Medicine of Cornell University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Pappas","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A","family":"Cornely","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany"},{"name":"German Centre for Infection Research, partner site Bonn-Cologne, Cologne, Germany"},{"name":"CECAD Cluster of Excellence, University of Cologne, Cologne, Germany"},{"name":"Clinical Trials Center Cologne, University Hospital of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Perfect","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P","family":"Kontoyiannis","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Infection Control and Employee Health, MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"2020080503205233900_CIT0001","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2710.2010.01166.x","article-title":"Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology","volume":"36","author":"des Champs-Bro","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"2020080503205233900_CIT0002","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Mu\u00f1oz","year":"2015","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0003","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0004","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"2020080503205233900_CIT0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12879-018-3410-4","article-title":"Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America","volume":"18","author":"Stultz","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2020080503205233900_CIT0006","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/jac\/dky270","article-title":"Trends in antifungal use in US hospitals, 2006-12","volume":"73","author":"Vallabhaneni","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0007","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0008","first-page":"195","article-title":"Evaluation of appropriate use of antifungal therapy in a tertiary care hospital","volume":"8","author":"Islahudin","year":"2015","journal-title":"Asian J Pharm Clin Res"},{"key":"2020080503205233900_CIT0009","doi-asserted-by":"crossref","first-page":"e01464-17","DOI":"10.1128\/AAC.01464-17","article-title":"Overtreatment of asymptomatic candiduria among hospitalized patients: a multi-institutional study","volume":"62","author":"Jacobs","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-0758-3","article-title":"Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: data from multinational Defining Antibiotic Levels in Intensive Care Unit (DALI) patients Study","volume":"19","author":"Sinnollareddy","year":"2015","journal-title":"Crit Care"},{"key":"2020080503205233900_CIT0011","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cid\/cix130","article-title":"Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis","volume":"64","author":"Lamoth","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0012","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/QCO.0000000000000497","article-title":"Antifungal stewardship: developments in the field","volume":"31","author":"Urbancic","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2020080503205233900_CIT0013","article-title":"How to improve antifungal stewardship","author":"Gohlar","year":"2019"},{"key":"2020080503205233900_CIT0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cmi.2018.03.033","article-title":"Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach","volume":"25","author":"Pulcini","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0015","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1093\/cid\/ciu542","article-title":"Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention","volume":"59","author":"Pollack","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0016","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/jac\/dku497","article-title":"An international cross-sectional survey of antimicrobial stewardship programmes in hospitals","volume":"70","author":"Howard","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0017","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/jmm.0.000612","article-title":"An investigation of antifungal stewardship programmes in England","volume":"66","author":"Micallef","year":"2017","journal-title":"J Med Microbiol"},{"key":"2020080503205233900_CIT0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/664909","article-title":"Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program","volume":"33","author":"Standiford","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020080503205233900_CIT0019","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/653616","article-title":"Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center","volume":"31","author":"Apisarnthanarak","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020080503205233900_CIT0020","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/jac\/dkv040","article-title":"Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England","volume":"70","author":"Micallef","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0021","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s15010-013-0431-1","article-title":"A 6-year antifungal stewardship programme in a teaching hospital","volume":"41","author":"Mondain","year":"2013","journal-title":"Infection"},{"key":"2020080503205233900_CIT0022","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.cmi.2015.01.013","article-title":"Antifungal stewardship in a tertiary-care institution: a bedside intervention","volume":"21","author":"Valerio","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0023","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0024","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ajic.2011.04.332","article-title":"The associations between organizational culture and knowledge, attitudes, and practices in a multicenter Veterans Affairs quality improvement initiative to prevent methicillin-resistant Staphylococcus aureus","volume":"40","author":"Sinkowitz-Cochran","year":"2012","journal-title":"Am J Infect Control"},{"key":"2020080503205233900_CIT0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/655459","article-title":"The importance of leadership in preventing healthcare-associated infection: results of a multisite qualitative study","volume":"31","author":"Saint","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020080503205233900_CIT0026","doi-asserted-by":"crossref","first-page":"i29","DOI":"10.1093\/jac\/dks200","article-title":"Addressing healthcare-associated infections and antimicrobial resistance from an organizational perspective: progress and challenges","volume":"67","author":"Murray","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0027","first-page":"121","article-title":"Board engagement in quality: findings of a survey of hospital and system leaders","volume":"53","author":"Jiang","year":"2008","journal-title":"J Healthc Manag"},{"key":"2020080503205233900_CIT0028","first-page":"15","article-title":"Board oversight of quality: any differences in process of care and mortality?","volume":"54","author":"Jiang","year":"2009","journal-title":"J Healthc Manag"},{"key":"2020080503205233900_CIT0029","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/1468-0009.12032","article-title":"Hospital board oversight of quality and patient safety: a narrative review and synthesis of recent empirical research","volume":"91","author":"Millar","year":"2013","journal-title":"Milbank Q"},{"key":"2020080503205233900_CIT0030","first-page":"1","article-title":"Leadership committed to safety","author":"Joint Commission on Accreditation of Healthcare Organizations","year":"2009","journal-title":"Sentinel Event Alert"},{"key":"2020080503205233900_CIT0031","first-page":"1","article-title":"Approved: new antimicrobial stewardship standard","volume":"36","author":"Joint Commission on Hospital Accreditation","year":"2016","journal-title":"Jt Comm Perspect"},{"key":"2020080503205233900_CIT0032","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jac\/dky538","article-title":"Antimicrobial stewardship: an evaluation of structure and process and their association with antimicrobial prescribing in NHS hospitals in England","volume":"74","author":"Scobie","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0033","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/cid\/cix651","article-title":"Uptake of antibiotic stewardship programs in US acute care hospitals: findings From the 2015 National Healthcare Safety Network Annual Hospital Survey","volume":"65","author":"O\u2019Leary","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0034","doi-asserted-by":"crossref","first-page":"ofw210","DOI":"10.1093\/ofid\/ofw210","article-title":"How to pitch an antibiotic stewardship program to the hospital C-suite","volume":"3","author":"Spellberg","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2020080503205233900_CIT0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2146\/ajhp160943","article-title":"Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005\u201315","volume":"74","author":"Fitzpatrick","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"2020080503205233900_CIT0036","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0037","doi-asserted-by":"crossref","first-page":"e00402","DOI":"10.1128\/AAC.00402-18","article-title":"A prospective real-world study of the impact of an antifungal stewardship program in a tertiary respiratory-medicine setting","volume":"62","author":"Nwankwo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0038","first-page":"1","article-title":"Antimicrobial stewardship staffing: how much is enough?","volume":"41","author":"Greene","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020080503205233900_CIT0039","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cmi.2017.07.013","article-title":"Human resources estimates and funding for antibiotic stewardship teams are urgently needed","volume":"23","author":"Pulcini","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0040","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1093\/jac\/dkw395","article-title":"The role of the multidisciplinary team in antifungal stewardship","volume":"71","author":"Agrawal","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0041","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/10428194.2017.1365861","article-title":"Acute myeloid leukemia and the infectious diseases consultant","volume":"59","author":"Mulanovich","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"2020080503205233900_CIT0042","first-page":"143","article-title":"Antibiotic stewardship teams and Clostridioides difficile practices in United States hospitals: a national survey in The Joint Commission antibiotic stewardship standard era","volume":"41","author":"Vaughn","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020080503205233900_CIT0043","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/cid\/cix407","article-title":"Antibiotic stewardship in small hospitals: barriers and potential solutions","volume":"65","author":"Stenehjem","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0044","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","author":"Ananda-Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"2020080503205233900_CIT0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10096-011-1397-5","article-title":"Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients","volume":"31","author":"Michallet","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0046","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3324\/haematol.2010.030825","article-title":"Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study","volume":"96","author":"Even","year":"2011","journal-title":"Haematologica"},{"key":"2020080503205233900_CIT0047","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.leukres.2014.01.007","article-title":"Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia","volume":"38","author":"Girmenia","year":"2014","journal-title":"Leuk Res"},{"key":"2020080503205233900_CIT0048","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2019.06.011","article-title":"Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia","volume":"141","author":"Weis","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"2020080503205233900_CIT0049","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2011.246","article-title":"ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia","volume":"47","author":"Arendrup","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2020080503205233900_CIT0050","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/cir122","article-title":"The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts","volume":"52","author":"Georgiadou","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0051","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/cid\/civ154","article-title":"High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies","volume":"60","author":"Stanzani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0052","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00259-018-4062-8","article-title":"FDG PET\/CT imaging in detecting and guiding management of invasive fungal infections: a retrospective comparison to conventional CT imaging","volume":"46","author":"Douglas","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2020080503205233900_CIT0053","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00259-011-1939-1","article-title":"18F-FDG PET\/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation","volume":"39","author":"Vos","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2020080503205233900_CIT0054","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/RLU.0b013e3181e4db84","article-title":"Utility of FDG PET\/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis","volume":"35","author":"Xu","year":"2010","journal-title":"Clin Nucl Med"},{"key":"2020080503205233900_CIT0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2214\/AJR.13.11712","article-title":"Potential role of 18F-FDG PET\/CT in patients with fungal infections","volume":"203","author":"Sharma","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2020080503205233900_CIT0056","doi-asserted-by":"crossref","first-page":"iii17","DOI":"10.1093\/jac\/dkt391","article-title":"Triggers for driving treatment of at-risk patients with invasive fungal disease","volume":"68","author":"Drgona","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0057","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2020080503205233900_CIT0058","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"2020080503205233900_CIT0059","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"\u03b2-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-\u03b2-D-glucan for Pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0061","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit Care"},{"key":"2020080503205233900_CIT0062","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0063","doi-asserted-by":"crossref","first-page":"e01756-17","DOI":"10.1128\/JCM.01756-17","article-title":"Efficacy of T2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: the serial therapeutic and antifungal monitoring protocol (STAMP) trial","volume":"56","author":"Mylonakis","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0064","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0065","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0066","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/mmy\/myx004","article-title":"An evaluation of the performance of the Dynamiker Fungus (1-3)-\u03b2-D-glucan assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia","volume":"55","author":"White","year":"2017","journal-title":"Med Mycol"},{"key":"2020080503205233900_CIT0067","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-\u03b2-D-glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"2020080503205233900_CIT0068","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0069","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jcp.2008.058354","article-title":"Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients","volume":"62","author":"Barnes","year":"2009","journal-title":"J Clin Pathol"},{"key":"2020080503205233900_CIT0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(13)70076-8","article-title":"Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial","volume":"13","author":"Morrissey","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2020080503205233900_CIT0071","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bmt.2008.355","article-title":"A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT","volume":"43","author":"Hebart","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2020080503205233900_CIT0072","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0073","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1200\/JCO.2009.21.8032","article-title":"Clinically driven diagnostic antifungal approach in neutropenic patients: a prospective feasibility study","volume":"28","author":"Girmenia","year":"2010","journal-title":"J Clin Oncol"},{"key":"2020080503205233900_CIT0074","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0075","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0076","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0077","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/1471-2334-14-385","article-title":"Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU","volume":"14","author":"Bruy\u00e8re","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020080503205233900_CIT0078","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit Care Med"},{"key":"2020080503205233900_CIT0079","doi-asserted-by":"crossref","first-page":"R198","DOI":"10.1186\/cc10366","article-title":"Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study","volume":"15","author":"Hermsen","year":"2011","journal-title":"Crit Care"},{"key":"2020080503205233900_CIT0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2009.01756.x","article-title":"Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit","volume":"54","author":"Ostrosky-Zeichner","year":"2011","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0081","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2019.04.002","article-title":"Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies","volume":"78","author":"Stanzani","year":"2019","journal-title":"J Infect"},{"key":"2020080503205233900_CIT0082","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"2020080503205233900_CIT0083","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2007.01375.x","article-title":"Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders","volume":"50","author":"Maertens","year":"2007","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0084","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/cit498","article-title":"Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia","volume":"57","author":"Huang","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0086","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/civ447","article-title":"Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing","volume":"61","author":"Banerjee","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0087","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/JCM.00751-06","article-title":"Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs","volume":"44","author":"Forrest","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0088","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.2146\/ajhp110604","article-title":"Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections","volume":"69","author":"Heil","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"2020080503205233900_CIT0089","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"Nguyen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2217\/fmb.15.29","article-title":"The economic impact of rapid Candida species identification by T2Candida among high-risk patients","volume":"10","author":"Bilir","year":"2015","journal-title":"Future Microbiol"},{"key":"2020080503205233900_CIT0091","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14737159.2018.1522250","article-title":"Recent advances in the molecular diagnosis of mucormycosis","volume":"18","author":"Dadwal","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"2020080503205233900_CIT0092","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020080503205233900_CIT0093","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"},{"key":"2020080503205233900_CIT0094","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/JCM.01405-12","article-title":"Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness","volume":"50","author":"Tan","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0095","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/JCM.00996-16","article-title":"Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program","volume":"54","author":"MacVane","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0096","doi-asserted-by":"crossref","first-page":"e01597","DOI":"10.1128\/JCM.01597-18","article-title":"Evaluation of the ePlex blood culture identification panels for detection of pathogens in bloodstream infections","volume":"57","author":"Huang","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0097","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2005.10.011","article-title":"Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures","volume":"54","author":"Alexander","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0098","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-0711-12-2","article-title":"Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study","volume":"12","author":"Harris","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2020080503205233900_CIT0099","doi-asserted-by":"crossref","first-page":"e01329-17","DOI":"10.1128\/JCM.01329-17","article-title":"Multicenter evaluation of the accelerate PhenoTest BC Kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis","volume":"56","author":"Pancholi","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0100","doi-asserted-by":"crossref","first-page":"iv27","DOI":"10.1093\/jac\/dky046","article-title":"Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system","volume":"73","author":"Patch","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0101","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JCM.02971-15","article-title":"Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected candidemia","volume":"54","author":"Walker","year":"2016","journal-title":"J Clin Microbiol"},{"key":"2020080503205233900_CIT0102","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12879-015-0809-z","article-title":"How much European prescribing physicians know about invasive fungal infections management?","volume":"15","author":"Valerio","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2020080503205233900_CIT0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2011.07.013","article-title":"Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review","volume":"39","author":"Sinnollareddy","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"2020080503205233900_CIT0104","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/CCM.0b013e31818b3477","article-title":"Treatment-related risk factors for hospital mortality in Candida bloodstream infections","volume":"36","author":"Labelle","year":"2008","journal-title":"Crit Care Med"},{"key":"2020080503205233900_CIT0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.diagmicrobio.2013.11.012","article-title":"Improving the management of candidemia through antimicrobial stewardship interventions","volume":"78","author":"Reed","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0106","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jac\/dkx388","article-title":"A systematic review of interventions and performance measures for antifungal stewardship programmes","volume":"73","author":"Bienvenu","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0107","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/338404","article-title":"Pulmonary candidiasis in patients with cancer: an autopsy study","volume":"34","author":"Kontoyiannis","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0108","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/myc.12024","article-title":"Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?","volume":"56","author":"Georgiadou","year":"2013","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0109","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1097\/CCM.0b013e3181760f42","article-title":"Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp","volume":"36","author":"Playford","year":"2008","journal-title":"Crit Care Med"},{"key":"2020080503205233900_CIT0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3855\/jidc.2623","article-title":"Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India","volume":"7","author":"Chander","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"2020080503205233900_CIT0111","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cid\/ciy849","article-title":"Impact of infectious disease consultation on clinical management and mortality in patients with candidemia","volume":"68","author":"Lee","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmi.2014.07.006","article-title":"Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation","volume":"21","author":"Farmakiotis","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0113","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S1473-3099(19)30405-0","article-title":"Effect of infectious disease consultation on mortality and treatment of patients with Candida bloodstream infections: a retrospective, cohort study","volume":"19","author":"Mejia-Chew","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2020080503205233900_CIT0114","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.2146\/ajhp170113","article-title":"Impact of automatic infectious diseases consultation on the management of fungemia at a large academic medical center","volume":"74","author":"Jones","year":"2017","journal-title":"Am J Health Syst Pharm"},{"key":"2020080503205233900_CIT0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/1120009X.2018.1507086","article-title":"Impact of infectious diseases consultation as a part of an antifungal stewardship programme on candidemia outcome in an Italian tertiary-care, university hospital","volume":"30","author":"Menichetti","year":"2018","journal-title":"J Chemother"},{"key":"2020080503205233900_CIT0116","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1093\/ofid\/ofx163.050","article-title":"Treatment bundle improves outcomes in the management of candidemia at large urban academic medical center","volume":"4","author":"Cook","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020080503205233900_CIT0117","doi-asserted-by":"crossref","first-page":"e0215996","DOI":"10.1371\/journal.pone.0215996","article-title":"The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years","volume":"14","author":"Ishikane","year":"2019","journal-title":"PLoS One"},{"key":"2020080503205233900_CIT0118","first-page":"558","article-title":"Impact of infectious diseases consultation on mortality of cryptococcal infection in patients without HIV","volume":"64","author":"Spec","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0119","first-page":"1522","article-title":"Antifungal stewardship programs and candidemia","volume":"70","author":"Tascini","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/603585","article-title":"Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the Infectious Diseases Society of America","volume":"49","author":"Kontoyiannis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0121","first-page":"833","article-title":"Mucormycosis in two community hospitals and the role of infectious disease consultation: a case series","volume":"6","author":"Dai","year":"2013","journal-title":"Int J Gen Med"},{"key":"2020080503205233900_CIT0122","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11908-019-0697-2","article-title":"The current and future use of telemedicine in infectious diseases practice","volume":"21","author":"Coombes","year":"2019","journal-title":"Curr Infect Dis Rep"},{"key":"2020080503205233900_CIT0123","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13643-019-1056-y","article-title":"Telemedicine infectious diseases consultations and clinical outcomes: a systematic review and meta-analysis protocol","volume":"8","author":"Burnham","year":"2019","journal-title":"Syst Rev"},{"key":"2020080503205233900_CIT0124","first-page":"3","article-title":"Impact of an antifungal stewardship intervention on optimization of candidemia management","volume":"5","author":"Rac","year":"2018","journal-title":"Ther Adv Infect Dis"},{"key":"2020080503205233900_CIT0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/phar.1186","article-title":"Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia","volume":"33","author":"Antworth","year":"2013","journal-title":"Pharmacotherapy"},{"key":"2020080503205233900_CIT0126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jac\/dku414","article-title":"Management bundles for candidaemia: the impact of compliance on clinical outcomes","volume":"70","author":"Takesue","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0127","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/IPC.0b013e318059b95f","article-title":"Compliance with Infectious Diseases Society of America guidelines for ophthalmologic evaluation of patients with candidemia","volume":"15","author":"Popovich","year":"2007","journal-title":"Infect Dis Clin Pract"},{"key":"2020080503205233900_CIT0128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diagmicrobio.2004.12.010","article-title":"Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines","volume":"52","author":"Patel","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0129","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s10096-018-3285-8","article-title":"Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship","volume":"37","author":"Mellinghoff","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0130","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/jac\/dkq240","article-title":"Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study)","volume":"65","author":"Pagano","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0131","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/myc.12746","article-title":"EQUAL Candida score: an ECMM score derived from current guidelines to measure quality of clinical candidaemia management","volume":"61","author":"Mellinghoff","year":"2018","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0132","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/myc.12820","article-title":"EQUAL aspergillosis score 2018: an ECMM score derived from current guidelines to measure quality of the clinical management of invasive pulmonary aspergillosis","volume":"61","author":"Cornely","year":"2018","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0133","doi-asserted-by":"crossref","first-page":"ofy299","DOI":"10.1093\/ofid\/ofy299","article-title":"EQUAL Cryptococcus score 2018: a European confederation of medical mycology score derived from current guidelines to measure quality of clinical cryptococcosis management","volume":"5","author":"Spec","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020080503205233900_CIT0134","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/jac\/dkz051","article-title":"Development and validation of the European Quality (EQUAL) score for mucormycosis management in haematology","volume":"74","author":"Koehler","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jgf2.159","article-title":"Antimicrobial stewardship without infectious disease physician for patients with candidemia: a before and after study","volume":"19","author":"Murakami","year":"2018","journal-title":"J Gen Fam Med"},{"key":"2020080503205233900_CIT0136","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation","volume":"11","author":"Jarvis","year":"2012","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"2020080503205233900_CIT0137","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/cid\/ciy567","article-title":"Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in antiretroviral-naive human immunodeficiency virus-infected adults with CD4 cell counts &lt;100\/\u03bcL: a systematic review and meta-analysis","volume":"68","author":"Temfack","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0138","volume-title":"Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"World Health Organization","year":"2018"},{"key":"2020080503205233900_CIT0139","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40121-020-00281-x","article-title":"Efficacy of a \u201cchecklist\u201d intervention bundle on the clinical outcome of patients with candida bloodstream infections: a quasi-experimental pre-post study","volume":"9","author":"Vena","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2020080503205233900_CIT0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0142","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0143","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0144","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2019.0733","article-title":"Utility of ophthalmologic screening for patients with Candida bloodstream infections: a systematic review","volume":"137","author":"Breazzano","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"2020080503205233900_CIT0145","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.ijid.2012.12.014","article-title":"Do all candidemic patients need an ophthalmic examination?","volume":"17","author":"Vinikoor","year":"2013","journal-title":"Int J Infect Dis"},{"key":"2020080503205233900_CIT0146","doi-asserted-by":"crossref","first-page":"e0183485","DOI":"10.1371\/journal.pone.0183485","article-title":"Is routine ophthalmoscopy really necessary in candidemic patients?","volume":"12","author":"Vena","year":"2017","journal-title":"PLoS One"},{"key":"2020080503205233900_CIT0147","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0148","doi-asserted-by":"crossref","first-page":"S617","DOI":"10.1093\/ofid\/ofz360.1552","article-title":"Invasive ocular candidiasis: who is really at risk?","volume":"6","author":"Seidelman","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2020080503205233900_CIT0149","first-page":"517","article-title":"Leading practices in antimicrobial stewardship: conference summary","volume":"45","author":"Baker","year":"2019","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2020080503205233900_CIT0150","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s10096-019-03626-8","article-title":"Antimicrobial stewardship by academic detailing improves antimicrobial prescribing in solid organ transplant patients","volume":"38","author":"So","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0151","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/cid\/ciz650","article-title":"Sustainability of handshake stewardship: extending a hand is effective years later","volume":"70","author":"MacBrayne","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0152","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/CMR.00066-16","article-title":"Antimicrobial stewardship: how the microbiology laboratory can right the ship","volume":"30","author":"Morency-Potvin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2020080503205233900_CIT0153","first-page":"537","article-title":"What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback?","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0154","doi-asserted-by":"crossref","first-page":"e199369","DOI":"10.1001\/jamanetworkopen.2019.9369","article-title":"Feasibility of core antimicrobial stewardship interventions in community hospitals","volume":"2","author":"Anderson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2020080503205233900_CIT0155","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s10096-018-3335-2","article-title":"Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship","volume":"37","author":"Valerio","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020080503205233900_CIT0156","first-page":"1390","article-title":"Closing the gap in surveillance and audit of invasive mold diseases for antifungal stewardship using machine learning","volume":"8","author":"Baggio","year":"2019","journal-title":"J Clin Med Res"},{"key":"2020080503205233900_CIT0157","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1128\/AAC.00572-16","article-title":"Investigating the extremes of antibiotic use with an epidemiologic framework","volume":"60","author":"Scheetz","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0158","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/mmy.38.s1.173.182","article-title":"Epidemiology: surveillance of fungal infections","volume":"38","author":"Ellis","year":"2000","journal-title":"Med Mycol"},{"key":"2020080503205233900_CIT0159","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/S1473-3099(17)30443-7","article-title":"Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks","volume":"17","author":"Benedict","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020080503205233900_CIT0160","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0161","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1182\/bloodadvances.2019000634","article-title":"Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study","volume":"3","author":"Multani","year":"2019","journal-title":"Blood Adv"},{"key":"2020080503205233900_CIT0162","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.md.0000091182.93122.8e","article-title":"Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy","volume":"82","author":"Antoniadou","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"2020080503205233900_CIT0163","doi-asserted-by":"crossref","first-page":"O50","DOI":"10.1111\/1469-0691.12312","article-title":"A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies","volume":"20","author":"Gamaletsou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0164","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1592\/phco.2005.25.9.1174","article-title":"Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy","volume":"25","author":"Lionakis","year":"2005","journal-title":"Pharmacotherapy"},{"key":"2020080503205233900_CIT0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2012.06795.x","article-title":"The impact of azole resistance on aspergillosis guidelines","volume":"1272","author":"Georgiadou","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"2020080503205233900_CIT0166","volume-title":"M27-A3: reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u20143rd ed","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"2020080503205233900_CIT0167","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.cmi.2016.01.017","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2020080503205233900_CIT0168","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.02163-13","article-title":"Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates","volume":"58","author":"Eschenauer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0169","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0170","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0171","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1086\/430710","article-title":"Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer","volume":"41","author":"Chamilos","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0172","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"2020080503205233900_CIT0173","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0174","volume-title":"M39-A4 analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline\u20144th ed","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"2020080503205233900_CIT0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13693780802291445","article-title":"The relationship between antifungal usage and antifungal susceptibility in clinical isolates of Candida: a multicenter Korean study","volume":"47","author":"Kim","year":"2009","journal-title":"Med Mycol"},{"key":"2020080503205233900_CIT0176","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1093\/jac\/dkr394","article-title":"Antifungal use influences Candida species distribution and susceptibility in the intensive care unit","volume":"66","author":"Fournier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0177","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/AAC.01144-13","article-title":"Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure","volume":"57","author":"Lewis","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0178","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"key":"2020080503205233900_CIT0179","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002\u20132010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"key":"2020080503205233900_CIT0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jof4010027","article-title":"Non-culture diagnostics for invasive candidiasis: promise and unintended consequences","volume":"4","author":"Clancy","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2020080503205233900_CIT0181","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3201\/eid2111.150404","article-title":"Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA","volume":"21","author":"Jung","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2020080503205233900_CIT0182","first-page":"3488","article-title":"Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital","volume":"73","author":"Rautemaa-Richardson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0183","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/AAC.00054-16","article-title":"Drug-drug interaction associated with mold-active triazoles among hospitalized patients","volume":"60","author":"Andes","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0184","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0185","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cis599","article-title":"The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial","volume":"55","author":"Park","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0186","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1128\/AAC.00802-12","article-title":"Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration","volume":"56","author":"Dolton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0187","doi-asserted-by":"crossref","first-page":"e01245","DOI":"10.1128\/AAC.01245-19","article-title":"Impact of triazole therapeutic drug monitoring availability and timing","volume":"63","author":"McCreary","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0188","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/17425255.2019.1671971","article-title":"Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients","volume":"15","author":"John","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2020080503205233900_CIT0189","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/INF.0b013e31825d3091","article-title":"Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation","volume":"31","author":"Watt","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"2020080503205233900_CIT0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s002280000216","article-title":"Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole","volume":"56","author":"Muhl","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"2020080503205233900_CIT0191","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/cid\/ciu657","article-title":"Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children","volume":"59","author":"van der Elst","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0192","doi-asserted-by":"crossref","first-page":"e00585-18","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0193","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dky463","article-title":"Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases","volume":"74","author":"Kaindl","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0194","doi-asserted-by":"crossref","first-page":"e01643","DOI":"10.1128\/AAC.01643-18","article-title":"Pharmacokinetics of intravenous isavuconazole in solid-organ transplant recipients","volume":"62","author":"Wu","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2020080503205233900_CIT0195","doi-asserted-by":"crossref","first-page":"e12878","DOI":"10.1111\/tid.12878","article-title":"Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation","volume":"20","author":"Kabulski","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"2020080503205233900_CIT0196","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijantimicag.2016.02.004","article-title":"Pharmacokinetic\/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations","volume":"47","author":"Yang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2020080503205233900_CIT0197","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/INF.0000000000001268","article-title":"Pharmacokinetics and safety of micafungin in infants supported with extracorporeal membrane oxygenation","volume":"35","author":"Autmizguine","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"2020080503205233900_CIT0198","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/dkw352","article-title":"Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation","volume":"72","author":"Jullien","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0199","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/cid\/ciz741","article-title":"Posaconazole serum drug levels associated with pseudohyperaldosteronism [manuscript published online ahead of print 12 August 2019]","volume":"70","author":"Nguyen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0200","first-page":"1621","article-title":"Breakthrough invasive mold infections in the hematology patient: current concepts and future directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0201","doi-asserted-by":"crossref","first-page":"212600","DOI":"10.7573\/dic.212600","article-title":"Challenges and research priorities to progress the impact of antimicrobial stewardship","volume":"8","author":"Bassetti","year":"2019","journal-title":"Drugs Context"},{"key":"2020080503205233900_CIT0202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cid\/ciw787","article-title":"Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings","volume":"64","author":"Moehring","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0203","volume-title":"National Healthcare Safety Network","author":"Centers for Disease Control and Prevention"},{"key":"2020080503205233900_CIT0204","volume-title":"ATC\/DDD Index","author":"World Health Organization Collaborating Centers"},{"key":"2020080503205233900_CIT0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40506-014-0015-3","article-title":"Antimicrobial stewardship programs: appropriate measures and metrics to study their impact","volume":"6","author":"Morris","year":"2014","journal-title":"Curr Treat Options Infect Dis"},{"key":"2020080503205233900_CIT0206","doi-asserted-by":"crossref","first-page":"vi71","DOI":"10.1093\/jac\/dkr459","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe","volume":"66","author":"Adriaenssens","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2020080503205233900_CIT0207","volume-title":"Antimicrobial consumption database (ESAC-Net)","author":"European Centre for Disease Prevention and Control"},{"key":"2020080503205233900_CIT0208","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jama.2014.12923","article-title":"Prevalence of antimicrobial use in US acute care hospitals, May-September 2011","volume":"312","author":"Magill","year":"2014","journal-title":"JAMA"},{"key":"2020080503205233900_CIT0209","volume-title":"National Healthcare Safety Network","author":"Centers for Disease Control and Prevention"},{"key":"2020080503205233900_CIT0210","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/cid\/ciw658","article-title":"Measuring appropriate antimicrobial use: attempts at opening the black box","volume":"63","author":"Spivak","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020080503205233900_CIT0211","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4081\/idr.2017.6821","article-title":"A systematic review of quality indicators for appropriate antibiotic use in hospitalized adult patients","volume":"9","author":"Kallen","year":"2017","journal-title":"Infect Dis Rep"},{"key":"2020080503205233900_CIT0212","first-page":"14840","article-title":"Invasive fungal disease in university hospital: a PCR-based study of autopsy cases","volume":"8","author":"Ruangritchankul","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"2020080503205233900_CIT0213","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12703\/P6-81","article-title":"Epidemiology of invasive fungal diseases on the basis of autopsy reports","volume":"6","author":"Dignani","year":"2014","journal-title":"F1000Prime Rep"},{"key":"2020080503205233900_CIT0214","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"2020080503205233900_CIT0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/j.1875-9114.2012.01154.x","article-title":"Antimicrobial stewardship: a matter of process or outcome?","volume":"32","author":"Khadem","year":"2012","journal-title":"Pharmacotherapy"},{"key":"2020080503205233900_CIT0216","first-page":"FC27","article-title":"Prescribing pattern of antifungal medications at a tertiary care hospital in Oman","volume":"10","author":"Al Balushi","year":"2016","journal-title":"J Clin Diagn Res"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_3\/S175\/33566595\/jiaa394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/222\/Supplement_3\/S175\/33566595\/jiaa394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T11:24:42Z","timestamp":1667129082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/222\/Supplement_3\/S175\/5880881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":216,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2020,8,5]]},"published-print":{"date-parts":[[2020,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa394","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2020,8,5]]}}}